Effects of phosphodiester and phosphorothioate antisense oligodeoxynucleotides on cell lines which overexpress c-myc: Implications for the treatment of Burkitt's lymphoma

Annals of Oncology

Volumn 8, Issue SUPPL. 1, 1997, Pages

  Williams, S A ^a   Gillan, E R ^a   Knoppel, E ^a   Buzby, J S ^a   Suen, Y ^a   Cairo, M S ^a  

^a CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

Author keywords

antisense; Burkitt's lymphoma; HL 60; phosphorothioate; Raji

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE;

BURKITT LYMPHOMA; CANCER RESEARCH; CELL PROLIFERATION; CELL STRAIN HL 60; CLONOGENIC ASSAY; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG RESEARCH; DRUG SCREENING; GENE EXPRESSION; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL; RAJI CELL;

EID: 0030916623     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/8.suppl_1.S25     Document Type: Conference Paper

References (38)

1. Magrath I. The pathogenesis of Burkilt's lymphoma. Adv Cancer Res 1990; 55: 133.
2. Raimondi S. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood 1993; 81(9): 2237.
3. Kadin M, Sako D, Berliner N et al. Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy. Blood 1986; 68: 1042.
4. Kinney M, Greer J, Glick A et al. Anaplastic large-cell Ki-1 malignant lymphomas: Recognition, biological and clinical implications. Pathol Annu 1991; 26: 1.
5. Showe L, Croce C. The role of chromosomal translocations in B and T cell neoplasia. Ann Rev Immunol 1987; 5: 253.
6. Gribben J, Freedman A, Neuberg D et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 1991; 325: 1525.
7. Croce C, Nowell P. Molecular basis of human B cell neoplasia. Blood 1985; 65: 1.
8. Taub R, Moulding C, Battey J et al. Activation and somatic mutation of the translocated c-myc gene in Burkitt's lymphoma cells. Cell 1984; 36: 339.
9. Yang Y, Ciarletta A, Temple P et al. Human interleukin-3 (multi-CSF): Identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3. Cell 1986; 47: 3.
10. Holt J, Redner R, Nienhuis A. An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation. Mol Cell Biol 1988; 8: 963.
11. Wickstrom E, Bacon T, Gonzalez A et al. Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA. Proc Natl Acad Sci USA 1988; 85: 1028.
12. Holt J, Redner R, Nienhuis A. An oligomer complementary to c-myc mRNA inhibits proliferaiton of HL-60 promyelocytic cells and induces differentiation. Mol Cell Biol 1988; 8: 963.
13. Loke S, Stein C, Zhang X et al. Delivery of c-myc antisense phosphorothioate oligodeoxynucleotides to hematopoietic cells in culture by liposome fusion: specific reduction in c-myc protein expression correlates with inhibition of cell growth and DNA synthesis. Curr Top Microbiol Immunol 1988; 141: 282.
14. 1. Nature 1987; 328: 445.
15. Bacon T, Wickstrom E. Walking along human c-myc mRNA with antisense oligodeoxynucleotides: Maximum efficacy at the 5′ cap region. Oncogene Res 1991; 6: 13.
16. Calabretta B. Inhibition of protooncogene expression by antisense oligodeoxynucleotides: biological and therapeutic implications. Cancer Res 1991; 51: 4505.
17. Szczylik C, Skorski T, Nicolaides N et al. Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides. Science 1991; 253: 562.
18. Calabretta B, Sims R, Valtieri M et al. Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: An in vitro study relevant to bone marrow purging. Proc Natl Acad Sci USA 1991; 88: 2351.
19. Miller P. Non-ionic antisense oligonucleotides. In Cohen J (ed): Oligodeoxynucleotides: Antisense Inhibitors of Gene Expression. London: Macmillan 1989; 79.
20. Stein C, Cohen J. Phosphorothioate oligodeoxynucleotide analogues. In Cohen J (ed): Oligodeoxynucleotides: Antisense Inhibitors of Gene Expression. London: Macmillan, 1989; 97.
21. Neekers L, Whitesell L, Rosolen A, Geselowitz D. Antisense inhibition of oncogene expression. Crit Rev Oncogenesis 1992; 3: 175.
22. Claude H. Rational design of sequence-specific oncogene inhibition based on antisense and antigene oligonucleotides. Eur J Cancer 1991; 27: 1466.
23. Kaltenbach MJ, Kaltenback M, Lyons W. Nigrosin as a dye for differentiating live and dead ascites cells. Exp Cell Res 1958; 15: 112.
24. Biro S, Fu Y-M, Yu Z-X, Epstein S. Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration. Proc Natl Acad Sci USA 1993; 90: 654.
25. Ghosh MK, Cohen JS. Oligodeoxynucleotides as antisense inhibitors of gene expression. Prog Nucleic Acid Res Mol Biol 1992; 42: 79.
26. Marcu KB, Bossone SA, Patel AJ. Myc function and regulation. Ann Rev Biochem 1992; 61: 309.
27. Hann S, Eisenman R. Proteins encoded by the human c-myc oncogene: Differential expression in neoplastic cells. Mol Cell Biol 1984; 4: 2486.
28. Stein C, Subasinghe C, Shinozuka K, Cohen J. Physico-chemical properties of phosphorothioate oligodeoxynucleotides. Nucleic Acids Res 1988; 16: 3209.
29. Stein CA, Mori K, Loke SL et al. Phosphorothioate and normal oligodeoxyribonucleotides with 5′-linked acridine: Characterization and preliminary kinetics of cellular uptake. Gene 1988; 72(1-2): 333.
30. Yaswen P, Stampfer M, Ghosh K, Cohen J. Effects of sequence of thioated oligonucleotides on cultured human mammary epithelia cells. Antisense Res Dev 1993; 3: 67.
31. McManaway M, Neckers L, Loke S et al. Tumour-specific inhibition of lymphoma growth by an antisense oligodeoxynucleotide. Lancet 1990; 335: 808.
32. Leonetti JP, Rayner B, Lemaitre M et al. Antiviral activity of conjugates between poly (L-lysine) and synthetic oligodeoxyribonucleotides. Gene 1988; 72 (1-2): 323.
33. Feigner P, Gadek T, Holm M et al. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci 1987; 84: 7413.
34. Caplen N, Gao X, Hayes P et al. Gene therapy for cystic fibrosis in humans by lipsome-mediated DNA transfer: The production of resources and the regulatory process. Gene Ther 1994; 1: 139.
35. Colige A, Sokilov B, Nugent P et al. Use of an antisense oligonucleotide to inhibit expression of a mutated human procollagen gene (COLIA1) in transfected mouse 3T3 cells. Biochemistry 1993; 32 (1): 7.
36. Wagner R, Matteucci M, Lewis J et al. Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines. Science 1993; 260: 1510.
37. Bennett C, Chiang M, Chan H et al. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol Pharmacol 1992; 41: 1023.
38. Capaccioli S, DiPasquale G, Mini E et al. Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum. Biochem Biophys Res Com 1993; 197 (2): 818.